FTS reduces bleomycin-induced cytokine and chemokine production and inhibits pulmonary fibrosis in mice.

Abstract

Bleomycin (BLM), an antitumour drug, is known to cause interstitial pneumonia followed by pulmonary fibrosis, and has often been used to produce an animal model of pulmonary fibrosis. In the present study, we examined the effect of a nonapeptide thymic hormone, facteur thymique serique (FTS), on the murine lung fibrosis induced by intratracheal instillation… (More)

Topics

Cite this paper

@article{Yara2001FTSRB, title={FTS reduces bleomycin-induced cytokine and chemokine production and inhibits pulmonary fibrosis in mice.}, author={Sabrina Yara and K. Kawakami and Norifumi Kudeken and Madoka Tohyama and Kohji Teruya and Takumi Chinen and Akira Awaya and A.. Saito}, journal={Clinical and experimental immunology}, year={2001}, volume={124 1}, pages={77-85} }